Cannabis Rescheduling Is Here. What It Means for Business Valuations.
On April 22, 2026, the Acting Attorney General issued a final order reclassifying FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. A formal DEA hearing on broader cannabis rescheduling is scheduled to begin June 29, 2026. This is the most consequential shift in federal marijuana […]
Houlihan Capital acted as the exclusive financial advisor on the sale of Choice Labs
Choice Labs Date: September 30, 2023 Client: Choice Labs Sale to: Glorious Cannabis Company Industry: Cannabis Houlihan Capital (Chicago, IL) acted as the exclusive financial advisor on the sale of Choice Labs Holding Co, LLC (“Choice Labs”) to multi-state operator, Glorious Cannabis Company. The transaction closed on September 30, 2023. Headquartered on a 10-acre campus […]
Locke Lord’s Cannabis Podcast, “The Joint Status Report,” Invites Michael Norton as Guest Speaker
Locke Lord’s cannabis industry podcast, The Joint Status Report, invited Michael Norton, Director – Business Development, as guest speaker on October 7, 2019. Episode 11: Locke Lord’s Chicago Partners, David Standa and Mike Wilson, interview Michael Norton and discuss Houlihan Capital’s services offerings for the cannabis industry. Listen to the podcast here: To learn more […]